supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
supplement:
Yohimbine
Research Papers that Mention the Interaction
“The synergistic effect was blocked by the α2-adrenoceptor antagonist yohimbine and inhibited by the ADP scavenger system creatine phosphate/creatine phosphokinase and antibodies against αIIbβ3.”
Adhesion of human platelets to albumin is synergistically increased by lysophosphatidic acid and adrenaline in a donor-dependent fashion“The adrenergic blocking agents, Dibenamine, yohimbine , benzodioxanes, and Pris-coline, when given in divided doses, progressively block epinephrine and nor-epinephrine pressor effects as the doses of the blocking agents are increased.”
“We previously revealed that pre-treatment with yohimbine or JP-1302 attenuated renal ischemia/reperfusion injury by inhibition of α2C-adrenoceptor antagonist.”
Post-treatment with JP-1302 protects against renal ischemia/reperfusion-induced acute kidney injury in rats.“Furthermore, loser effects were partly eliminated by either injection of epinastine, an octopamine blocker, or yohimbine , a tyramine blocker, and significantly diminished by injection of a mixture of both blockers.”
“Co-administration of the α2-adrenoceptor antagonist yohimbine hastens the behavioral and neurogenic effects of the antidepressant imipramine.”
“reduced the formation of normetanephrine and theα-adrenoceptor antagonists yohimbine , 10 mg per kg i.p.,”
“Mice implanted for 5 days with osmotic minipumps containing the α2-adrenoceptor agonist clonidine showed symptoms of a withdrawal syndrome (jerks, headshakes, defecations and weight loss) when yohimbine , an α2-adrenoceptor antagonist, was injected.”
“During stimulation with 36 pulses at 3 Hz the α2-adrenoceptor antagonist yohimbine induced a five-fold increase of noradrenaline release indicating a pronounced autoinhibition of approximately 80%.”
“Pretreatment with either the beta-adrenoceptor antagonist nadolol or the selective alpha2-adrenoceptor antagonist yohimbine prevented both leukocyte peaks in the high volume group, suggesting a combined receptor activation.”
“Furthermore, these alpha 2- and beta-agonistic effects were almost completely inhibited in the presence of the alpha 2-adrenoceptor antagonist yohimbine and the beta-adrenoceptor antagonist propranolol at a concentration of 10(-6) mol/L, respectively.”
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback